|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,543.00 JPY | +1.99% |
|
+3.77% | +22.06% |
| Nov. 18 | Chugai Pharmaceutical to Absorb Renalys Pharma Following Full Acquisition | MT |
| Nov. 12 | Japan's Nikkei rises as SoftBank Group trims losses; Topix hits new high | RE |
| Capitalization | 14,059B 90.26B 76.89B 71.82B 67.58B 124B 8,175B 136B 838B 325B 3,854B 339B 332B | P/E ratio 2025 * |
32.8x | P/E ratio 2026 * | 29.3x |
|---|---|---|---|---|---|
| Enterprise value | 13,188B 84.66B 72.12B 67.37B 63.39B 117B 7,668B 127B 786B 305B 3,615B 318B 311B | EV / Sales 2025 * |
10.6x | EV / Sales 2026 * | 9.84x |
| Free-Float |
38.09% | Yield 2025 * |
2.97% | Yield 2026 * | 1.52% |
Last Transcript: Chugai Pharmaceutical Co., Ltd.
| 1 day | +1.99% | ||
| 1 week | +3.77% | ||
| Current month | +2.02% | ||
| 1 month | +5.56% | ||
| 3 months | +27.53% | ||
| 6 months | +14.56% | ||
| Current year | +22.06% |
| 1 week | 8,057 |  | 8,629 |
| 1 month | 8,023 | | 8,629 |
| Current year | 5,942 | | 8,655 |
| 1 year | 5,942 | | 8,655 |
| 3 years | 3,191 | | 8,655 |
| 5 years | 3,191 | | 8,655 |
| 10 years | 1,003.33 | | 8,655 |
| Manager | Title | Age | Since |
|---|---|---|---|
Osamu Okuda
CEO | Chief Executive Officer | 62 | 2020-12-31 |
Iwaaki Taniguchi
DFI | Director of Finance/CFO | - | 2024-03-27 |
Junichi Nezu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Motoo Ueno
BRD | Director/Board Member | 68 | 1993-02-28 |
Masayuki Oku
BRD | Director/Board Member | 81 | 2015-02-28 |
| Director/Board Member | 77 | 2017-02-28 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 6.57% | 27 M€ | +5.01% | - |
| 1.87% | 68 M€ | +20.57% | - |
| 1.59% | 5 M€ | +21.34% | - |
| 1.53% | 79,646 M€ | +27.27% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +1.99% | +3.77% | +29.56% | +136.06% | 90.26B | |
| +1.80% | +1.70% | +30.21% | +186.49% | 920B | |
| +0.75% | +4.78% | +44.31% | +18.06% | 510B | |
| -0.29% | -1.22% | +28.81% | +35.52% | 395B | |
| -0.35% | +1.90% | +25.12% | +3.11% | 340B | |
| -1.12% | -1.09% | +28.43% | +18.70% | 278B | |
| -0.45% | -1.48% | +20.24% | +24.41% | 254B | |
| +1.30% | +0.58% | -1.67% | -9.57% | 249B | |
| +0.45% | +3.73% | -57.41% | -30.85% | 224B | |
| +0.11% | -3.68% | +17.41% | +16.70% | 171B | |
| Average | +0.42% | +0.90% | +16.50% | +39.86% | 343.22B | |
| Weighted average by Cap. | +0.58% | +1.22% | +22.06% | +62.09% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 1,244B 7.99B 6.81B 6.36B 5.98B 11.01B 724B 12.03B 74.21B 28.78B 341B 29.98B 29.34B | 1,324B 8.5B 7.24B 6.76B 6.36B 11.72B 770B 12.8B 78.94B 30.62B 363B 31.89B 31.22B |
| Net income | 429B 2.75B 2.34B 2.19B 2.06B 3.79B 249B 4.14B 25.56B 9.91B 117B 10.32B 10.11B | 480B 3.08B 2.63B 2.45B 2.31B 4.25B 279B 4.64B 28.64B 11.11B 132B 11.57B 11.33B |
| Net Debt | -872B -5.6B -4.77B -4.45B -4.19B -7.71B -507B -8.43B -51.97B -20.16B -239B -21B -20.55B | -1,028B -6.6B -5.62B -5.25B -4.94B -9.1B -598B -9.94B -61.32B -23.79B -282B -24.77B -24.25B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 8,543.00 ¥ | +1.99% | 3,564,700 |
| 25-12-11 | 8,376.00 ¥ | +2.77% | 2,615,700 |
| 25-12-10 | 8,150.00 ¥ | -0.45% | 1,703,700 |
| 25-12-09 | 8,187.00 ¥ | -0.45% | 1,477,700 |
| 25-12-08 | 8,224.00 ¥ | -0.11% | 1,338,800 |
Delayed Quote Japan Exchange, December 12, 2025 at 01:30 am EST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4519 Stock
Select your edition
All financial news and data tailored to specific country editions
